Drug Profile
Adcon T/N
Alternative Names: Adcon-T/N; Adocon-T/NLatest Information Update: 23 Nov 2020
Price :
$50
*
At a glance
- Originator Wright Medical Group
- Developer Wright Medical Group; Wright Medical Japan
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Post-surgical adhesions
Most Recent Events
- 10 Nov 2020 Wright Medical Group has been acquired by Stryker Corporation
- 15 Oct 2009 No development reported - Preregistration for Post-surgical adhesions in Japan (Topical)
- 14 Mar 2003 Gliatech's Adcon® Gel technology has been purchased by Wright Medical Group, Inc.